nitrendipine has been researched along with Pulmonary Fibrosis in 2 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 10 patients with precapillary pulmonary hypertension due to pulmonary fibrosis, the arterial blood pressure, right heart hemodynamics, cardiac output, and arterial oxygen partial pressure were measured to evaluate the benefits of acute sublingual (5 mg) nitrendipine." | 7.67 | Effects of 5 mg sublingual nitrendipine in patients with precapillary pulmonary hypertension due to pulmonary fibrosis. ( Buhl, R; Burger, W; Jandl, M; Kober, G; Schultze-Werninghaus, G; Sievert, H, 1988) |
| "In 10 patients with precapillary pulmonary hypertension due to pulmonary fibrosis, the arterial blood pressure, right heart hemodynamics, cardiac output, and arterial oxygen partial pressure were measured to evaluate the benefits of acute sublingual (5 mg) nitrendipine." | 3.67 | Effects of 5 mg sublingual nitrendipine in patients with precapillary pulmonary hypertension due to pulmonary fibrosis. ( Buhl, R; Burger, W; Jandl, M; Kober, G; Schultze-Werninghaus, G; Sievert, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, W | 2 |
| Jandl, M | 2 |
| Gellert, J | 1 |
| Schultze-Werninghaus, G | 2 |
| Kober, G | 2 |
| Buhl, R | 1 |
| Sievert, H | 1 |
1 trial available for nitrendipine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Acute and chronic effects of nitrendipine in patients with precapillary pulmonary hypertension due to pulmonary fibrosis.
Topics: Adult; Atrial Function, Right; Blood Pressure; Female; Heart Rate; Humans; Hypertension, Pulmonary; | 1991 |
1 other study available for nitrendipine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Effects of 5 mg sublingual nitrendipine in patients with precapillary pulmonary hypertension due to pulmonary fibrosis.
Topics: Administration, Sublingual; Adult; Blood Pressure; Coronary Circulation; Exercise; Female; Humans; H | 1988 |